MODD logo

MODULAR MEDICAL INC

MODDNASDAQ
๐Ÿ† #4076 by market capEarnings Sep 2US Equity
$2.02โ–ฒ $0.02 (+0.75%)
๐ŸŒ… Pre-market$2.02โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ฒ 0.8%
7dโ–ผ 1.2%
14dโ–ผ 3.8%
30dโ–ผ 49.5%
1yโ–ผ 91.0%
๐ŸฆMarket Cap
$11M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
โ€”
๐Ÿ“ŠGross Margin
โ€”
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
โ€”
Otter Score
45
Weak

Trading Snapshot

Day Range
$1.99 โ€“ $2.05
52-Week Range
$1.92 โ€“ $30.00
Volume
$3.27B
Avg Volume
$3.30B
Shares Outstanding
5.4M
Next Earnings
Oct 24, 2026

Fundamentals Snapshot

Annual Revenue
$1M
Last Q Revenue
$275,628
P/E Ratio
โ€”
P/S Ratio
โ€”
EPS (TTM)
$-13.21
Dividend Yield
โ€”

Why Investors Own MODD

  • โœ“High-growth profile โ€” revenue up -7.4% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 26% gross margin and 14% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1Mโ–ผ โˆ’9.2% YoY
Gross Margin (TTM)
26.1%โ–ฒ +4.0% YoY
Operating Income (TTM)
$208,309โ–ผ โˆ’9.2% YoY
Free Cash Flow (TTM)
$147,867โ–ผ โˆ’9.2% YoY

About MODULAR MEDICAL INC

Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
45/100

Analyst Ratings

โ“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of May 2025

Latest News & Updates

๐Ÿš€
Benzingaยท9d ago

Modular Medical Launches Pivot Insulin Delivery System Across Five Key U.S. Markets

First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption of the Pivot Pump.

ChartMillยท11d ago

Top movers in Friday's after hours session

As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Benzingaยท19d ago

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Tenet Healthcare (NYSE:THC) shares rose 14.1% to $227.06 during Thursday's after-market session. The company's market cap stands at $17.1 billion. As per the news, the Q2 earnings report came out today.

Benzingaยท26d ago

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million. Agape ATP (NASDAQ:ATPC) shares moved upwards by

๐Ÿ›ฐ๏ธ
Benzingaยท28d ago

Modular Medical Announces Independent Study Supports Favorable Payor Receptivity To Pivot's Differentiated Design, Simplified User Experience

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today

๐ŸŒŒ
Benzingaยท29d ago

Modular Medical Survey Shows 97% Of Injection Users Open To Pump Therapy; Company Advancing Pivot Tubeless Insulin Patch Pump, To Present At ADCES Conference August 7โ€‘10

97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch